±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 530  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

dingjieboy

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] ÂÛÎÄСÐÞ£¬Éó¸åÈËÖ»ÌáÁËÒ»ÌõÐÞ¸ÄÒâ¼û£¬µ«²»Ì«ÈÝÒ×Ð޸ģ¬100½ð±ÒÇóÖú¡£

Ò»2Á½·Ö¶àµÄÔÓÖ¾£¬Ñо¿µÄÊÇLSD1¡¢E-cadherin¡¢N-cadherinÔÚijÖ×ÁöµÄ±í´ï¼°ÆäÁÙ´²ÒâÒå¡£Éó¸åÈËÒâ¼ûÈçÏ£ºThis study is a well done retrospective pathologic archive histologic classification of colon cancer based on LSD1 and E,N-cadherin with a concise and informative discussion of biology leading to metastasis and poor outcome.  In your discussion it would be important to note that prospective study to confirm these findings while at same time using a control group compared to LSD1 treatment group would be needed to validate theories of clinical applicability!¡£
ÎÒÏë°ÑÕâµãÒâ¼û¼Óµ½ÒÔÏÂÕâ¶Î»°ÖУ¬Çó½Ì¸÷λ¸ßÈ˰ïæÐ޸쬲»Éõ¸Ðл¡£
Due to the high structural and mechanistic similarities between LSD1 and amine oxidases, monoamine oxidase (MAO) inhibitors such as pargyline, tranylcypromine and polyamine analogues have been shown to inhibit LSD1 enzymatic activity [38]. In  vitro experiments, these inhibitors can inhibit LSD1 expression in cancer cells and affect a reexpression of multiple, aberrantly silenced genes important in the development of cancer [38]. Lv et al. reported that interruption of LSD1 using siRNA or pargyline could suppress proliferation, migration and invasion of non-small cell lung cancer cells [13]. Despite some good basic research results, further effort should be made to validate their clinical application value in cancer treatment.

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qfzcom

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-12-05 21:10:31
dingjieboy: ½ð±Ò+20, ·­ÒëEPI+1, ¡ïÓаïÖú, ¸ÐлÄúÌṩµÄ°ïÖú£¡µ«ÎÒÊÇÏë°ÑÉó¸åÈ˵ÄÒâ¼û£¨µÚÒ»¶ÎµÄºì×Ö²¿·Ö£©¼Óµ½ÎÒµÄÌÖÂÛ£¨µÚ¶þ¶ÎµÄºì×Ö²¿·Ö£¬ÉÐδÐ޸ģ©ÖÐÈ¥¡£Õâ¸öÉó¸åÈ˵ÄÒâ¼ûÒ²Óеã¹Ö£¬ÎÒ²¢Ã»ÓÐ×öµ½LSD1µÄ¸ÉԤʵÑ飬ֻÊÇ×öÁËLSD1¡¢E-cadherin¡¢N-cadherinÔڽ᳦°©±í´ïµÄ¼ì²â¡£È´ÒªÎÒÔÚÌÖÂÛ²¿·Ö¼ÓLSD1¸ÉÔ¤µÄÁÙ´²ÊµÑé½øÈ¥£¬ÊµÔÚΪÄÑ¡£ 2012-12-06 14:47:30
Due to the high structural and mechanistic similarities between LSD1 and amine oxidases, monoamine oxidase (MAO) inhibitors such as pargyline, tranylcypromine and polyamine analogues have been shown to inhibit LSD1 enzymatic activity [38]. In  vitro experiments these inhibitors can inhibit expression of LSD1 in cancer cells and affect a reexpression of multiple, aberrantly silenced genes important in the development of cancer [38]. Lv et al. reported that the interruption of LSD1 using siRNA or pargyline could suppress proliferation, migration and invasion of non-small cell lung cancer cells [13]. Despite some good basic research results, further efforts should be made to validate their clinical application value in cancer treatment.ÕûÌåÀ´ËµÐ´µÄ»¹¿ÉÒÔ£¬¾ÍÊÇÆäÖм¸¸öµØ·½ÉÔ΢ÐÞ¸ÄÁËһϣ¬¶¼ÊÇϸ½ÚÎÊÌ⣬ϸ½Ú¾ö¶¨³É°Ü¡£¼ÈÈ»¶¼µ½ÕâÒ»²½ÁË£¬¾ÍÈÏÕæÐÞ¸Äһϡ£ËµÊµ»°£¬Ð´µÄ²»´í£¬¼ÓÓÍ¡£
2Â¥2012-12-05 19:04:52
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ dingjieboy µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 357Çóµ÷¼Á +13 1050389037 2026-04-03 13/650 2026-04-03 22:27 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 311£¨085601£©Çóµ÷¼Á +15 liziyeyeye 2026-03-28 16/800 2026-04-03 21:43 by qlm5820
[¿¼ÑÐ] 281Çóµ÷¼Á +10 aaawhy 2026-04-03 10/500 2026-04-03 21:42 by lbsjt
[¿¼ÑÐ] 310Çóµ÷¼Á +18 ÕùÈ¡¾Åµã˯ 2026-03-30 18/900 2026-04-03 18:35 by lsÁõ˧
[¿¼ÑÐ] 313Çóµ÷¼Á +3 ¡«Î¢Î¢Á¹¡« 2026-04-03 3/150 2026-04-03 11:25 by à£à£à£0119
[¿¼ÑÐ] Çóµ÷¼Á +3 ÐÄÏëÊÂ³É¿É 2026-04-03 3/150 2026-04-03 11:22 by wangjy2002
[»ù½ðÉêÇë] ÇëÎʹ²Í¬Í¨Ñ¶ºÍ¹²Í¬Ò»×÷µÄÈϿɶÈÎÊÌâ 10+4 psa1234 2026-04-01 10/500 2026-04-03 11:08 by Kittylucky
[¿¼ÑÐ] 312Çóµ÷¼Á +4 ÉÞÔÂÉ« 2026-04-02 5/250 2026-04-03 08:21 by fangshan711
[¿¼ÑÐ] 260Çóµ÷¼Á +6 ÖìÜÆÁÕ 2026-04-02 6/300 2026-04-02 20:27 by 6781022
[¿¼ÑÐ] 285Çóµ÷¼Á +14 AZMK 2026-04-02 14/700 2026-04-02 15:54 by ÉϾÅÌìÀ¿Ô£¨ºÃÔ
[¿¼ÑÐ] 0832ʳƷ¿ÆÑ§Ó빤³Ìѧ˶282µ÷¼Á +4 ÓãÔÚË®ÖÐÓÎa 2026-04-02 7/350 2026-04-02 14:12 by baoball
[¿¼ÑÐ] ¿¼Ñе÷¼Á0702 +3 ÷×ÓζÍíϼ 2026-03-28 3/150 2026-04-02 10:10 by jp9609
[¿¼ÑÐ] 348»·¾³¹¤³Ìµ÷¼Á +3 ÎâÑå׿24k 2026-04-01 3/150 2026-04-02 09:14 by nanaliuyun
[¿¼ÑÐ] °²È«¹¤³Ì 285 Çóµ÷¼Á +3 Xinyu56 2026-04-01 4/200 2026-04-01 21:50 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] Çóµ÷¼Á0703 +5 ÖܼÎÒ¢ 2026-03-31 8/400 2026-04-01 20:32 by ltltkkk
[¿¼ÑÐ] 085600£¬321·ÖÇóµ÷¼Á +13 ´ó²öС×Ó 2026-03-31 13/650 2026-04-01 12:35 by chemdavid
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +10 Eujd1 2026-03-31 11/550 2026-04-01 11:23 by ivanqyq
[¿¼ÑÐ] Çó0861½»Í¨ÔËÊäר˶or²ÄÁÏר˶µ÷¼Á +4 ÀÕ²¼ÀÊ@ 2026-03-31 4/200 2026-04-01 09:54 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] 333Çóµ÷¼Á +4 °¢¿ÆÒÝ 2026-03-31 4/200 2026-04-01 09:11 by jp9609
[¿¼ÑÐ] ±¾¿ÆË«·Ç²ÄÁÏ£¬¿ç¿¼Ò»Ö¾Ô¸»ªµç085801µçÆø£¬283Çóµ÷¼Á£¬ÈκÎרҵ¶¼¿ÉÒÔ +6 ֥ʿѩbaoo 2026-03-28 8/400 2026-03-29 08:16 by ËÉ»¨¸×1201
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û